Nanotherics has launched the Magnefect-nano II, which, according to the company, offers gene transfection with improved efficiencies and cell viabilities.
According to the company, it works with a range of difficult cell types such as neuronal and primary cells.
It uses a technology applying proprietary magnet configurations and oscillating magnet arrays, which can operate at user-definable variable frequencies, to promote magnetic nanoparticle/DNA uptake into cells to improve non-viral gene transfection, while maintaining high cell viability.
The company claims that it is simple to use with low running costs (as low as $0.10 per transfection).
The device provides improved transfection efficiency and effectiveness over the best currently available cationic lipid agents at short transfection times (<30 minutes).
It allows retransfection, as well as adherent state transfection.
